S. Amarnani

Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.

R. Elashoff, A. Ribas, A. Cochran, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.

A. Ribas, L. Butterfield, W. McBride, 2000, Journal of immunotherapy.

T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.

A. Ribas, L. Butterfield, W. McBride, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

J. Wargo, A. Ribas, L. Butterfield, 2004, Journal of immunotherapy.

Green tea and the risk of gastric cancer: epidemiological evidence.

A. Bishayee, S. Amarnani, I-Chun Hou, 2013, World journal of gastroenterology.

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene–modified dendritic cell vaccines

A. Ribas, L. Ignarro, L. Butterfield, 2002, Cancer Gene Therapy.

Autocrine regulators of MC3T3‐E1 cell proliferation

S. Mohan, D. Baylink, T. Linkhart, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of selected endothelium-dependent vasodilators on fetoplacental vasculature: physiological implications.

G. Chaudhuri, S. Amarnani, B. Sangrat, 1999, American journal of physiology. Heart and circulatory physiology.

CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

A. Ribas, L. Butterfield, W. McBride, 2001, Cancer research.